Advance care planning in adolescents with cystic fibrosis: A quality improvement project. Issue 12 (17th October 2016)

• Record Type: Journal Article
• Authors: Kazmerski, Traci M.; Weiner, Daniel J.; Matisko, Janice; Schachner, Diane; Lerch, Whitney; May, Carol; Maurer, Scott H.
• Is Part Of: Pediatric pulmonology. Volume 51:Issue 12(2016:Dec.)
• Page Start: 1304
• Page End: 1310
• Publication Date: 2016-10-17
• Subjects: cystic fibrosis -- advance care planning -- end‐of‐life care; Pediatric respiratory diseases -- Periodicals; Pediatrics -- Periodicals; 618.922
• DOI: 10.1002/ppul.23559
• Languages: English
• ISSNs: 8755-6863

Abstract

Summary: Introduction: Advance care planning (ACP), though recommended, has not been studied in adolescents with cystic fibrosis (CF). This quality improvement project engaged adolescents with advanced CF disease in ACP and assessed patient and CF provider attitudes and preferences regarding ACP discussions and tools. Materials and Methods: Patients ≤22 years with advanced CF (FEV1 ≤40% predicted, >2 pulmonary exacerbations requiring IV antibiotics in 1 year, and/or use of home oxygen or non‐invasive ventilation) were referred to the pediatric palliative care team (PC). After establishing rapport, ACP was discussed using Voicing My CHOiCES™: An Advanced Care Planning Guide (VMC). Patients completed a survey assessing attitudes and preferences around ACP. PC also led a training session for CF providers around ACP and VMC and provider attitudes were assessed via a pre‐ and post‐training survey. Results: Twelve patients (mean age 17.9 ± 2.2 years) reviewed VMC and completed the ACP survey. The majority (83%) found ACP helpful. None felt it was harmful. All found VMC easy to understand and 90% felt it was appropriate for patients with CF. Of participating CF providers (pre‐training, n = 6; post‐training, n = 7), 83% found ACP worthwhile, but desired more training in this area. All found the training session useful and felt VMC was appropriate for patients with CF. Discussion: Adolescents with advanced CF disease felt ACP was a positive experience and not harmful. CF providers valued ACP, but desired more training. Both patients and providers felt that VMC was a useful, disease‐appropriate tool.Pediatr Pulmonol. 2016;51:1304–1310. © 2016 Wiley Periodicals, Inc.